News

Filter

Current filters:

ZetiaMylan Laboratories

101 to 110 of 96906 results

Dynamic growth of pharmaceutical sales to hospitals in Poland

Dynamic growth of pharmaceutical sales to hospitals in Poland

13-11-2014

The year 2013 was better for the Polish pharmaceutical distribution market than 2012, when wholesale…

Markets & MarketingPharmaceuticalPMRPolandPricing

Ukraine plans to ban drug imports from Russia

Ukraine plans to ban drug imports from Russia

13-11-2014

The Ukrainian government is considering imposing a ban on the import of drugs from Russia. This comes…

Markets & MarketingPharmaceuticalPoliticsRussiaUkraine

Takeda joins forces with GE Healthcare on liver disease research

Takeda joins forces with GE Healthcare on liver disease research

13-11-2014

Japan’s largest drugmaker Takeda Pharmaceutical has entered into an alliance agreement with UK-based…

GE HealthcareJapanNephrology and HepatologyPharmaceuticalResearchTakeda Pharmaceutical

ValiRx to collaborate with Deutsches Krebsforschungzentrum on further development of GeneICE

ValiRx to collaborate with Deutsches Krebsforschungzentrum on further development of GeneICE

13-11-2014

Cancer diagnostics and personalized medicines specialist ValiRx has agreed to collaborate with Deutsches…

BiologyBiotechnologyGermanyMedicineMolecular geneticsOncologyResearchValiRx

Ulcerative colitis market to hit $4.2 billion by 2023

Ulcerative colitis market to hit $4.2 billion by 2023

13-11-2014

The ulcerative colitis market is set to grow from $2.7 billion in 2013 to $4.2 billion in 2023 in the…

Decision Resources GroupEntyvioGastro-intestinalsGlobalMarkets & MarketingPharmaceuticalRemicadeResearchXeljanz

Par Pharmaceuticals receives FDA approval for Vasostrict in low blood pressure

Par Pharmaceuticals receives FDA approval for Vasostrict in low blood pressure

13-11-2014

Generic and branded specialty pharma company Par Pharmaceuticals has received approval for its New Drug…

HematologyPar PharmaceuticalsPharmaceuticalRegulationUSAVasostrict

Merck KGaA raises forecasts on solid third-quarter 2014

Merck KGaA raises forecasts on solid third-quarter 2014

13-11-2014

German pharma and chemicals firm Merck KGaA this morning reported that revenue for the third quarter…

FinancialGermanyMerck KGaAMerck SeronoPharmaceutical

SMC accepts Eylea and Onglyza for use in NHS Scotland

SMC accepts Eylea and Onglyza for use in NHS Scotland

13-11-2014

The Scottish Medicines Consortium (SMC) has accepted German drugmaker Bayer’s Eylea (aflibercept solution…

AstraZenecaBayerDiabetesEyleaOnglyzaPharmaceuticalRegulationUK

UPDATE: UK agrees “Patent Box” compromise with Germany

UPDATE: UK agrees “Patent Box” compromise with Germany

13-11-2014

Germany and the UK have agreed a joint proposal to advance the negotiations on new rules for preferential…

FinancialGermanyPatentsPharmaceuticalPoliticsUK

101 to 110 of 96906 results

Back to top